IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.382
EU - Europa 3.336
AS - Asia 682
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 6
AF - Africa 3
OC - Oceania 3
Totale 22.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.328
UA - Ucraina 1.588
DE - Germania 611
FI - Finlandia 539
CN - Cina 514
IE - Irlanda 251
SE - Svezia 174
TR - Turchia 115
IT - Italia 58
CA - Canada 52
GB - Regno Unito 35
RU - Federazione Russa 24
IN - India 19
EU - Europa 14
BE - Belgio 12
IR - Iran 12
NL - Olanda 8
TW - Taiwan 8
CH - Svizzera 7
FR - Francia 7
KR - Corea 7
PT - Portogallo 6
ES - Italia 3
PL - Polonia 3
RO - Romania 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
EE - Estonia 2
HU - Ungheria 2
SG - Singapore 2
BO - Bolivia 1
BS - Bahamas 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
MM - Myanmar 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TG - Togo 1
Totale 22.426
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.296
Fairfield 2.612
Ann Arbor 2.388
Houston 1.859
Jacksonville 1.185
Ashburn 1.097
Seattle 998
Wilmington 927
Cambridge 925
Dearborn 554
Chandler 528
Beijing 285
Princeton 265
Dublin 251
San Diego 138
Izmir 115
Ogden 56
Norwalk 49
Ottawa 42
Des Moines 41
Hefei 37
San Mateo 35
Nanjing 30
Boardman 28
Grafing 27
Kunming 22
New York 22
Udine 18
Nanchang 16
Helsinki 13
Jinan 13
Guangzhou 12
Andover 11
Leawood 10
Saint Petersburg 9
Wuhan 9
Brussels 8
Chongqing 8
Fuzhou 8
Augusta 7
Toronto 7
Hangzhou 6
Shenyang 6
Washington 6
Zhengzhou 6
Changsha 5
Hebei 5
Milan 5
Taipei 5
Zurich 5
Bremen 4
Edinburgh 4
Eindhoven 4
Falls Church 4
Vicenza 4
Ardabil 3
Baotou 3
Charlotte 3
Chengdu 3
Coimbra 3
Guarda 3
Henderson 3
Magione 3
Monmouth Junction 3
Venice 3
Warsaw 3
Bangalore 2
Bastia 2
Budapest 2
Chicago 2
Huzhou 2
Kashan 2
London 2
Mumbai 2
Nanning 2
Redmond 2
Sacramento 2
Santiago 2
Shanghai 2
Sint-Gillis-Waas 2
Tallinn 2
Wenzhou 2
Winnipeg 2
Xian 2
Yuncheng 2
Adelaide 1
Almería 1
Athens 1
Auckland 1
Bogotá 1
Bucharest 1
Cairo 1
Central 1
Chaoyang 1
Chennai 1
Cochabamba 1
Cormeilles-en-Parisis 1
Craigavon 1
Curitiba 1
Dallas 1
Totale 18.116
Salva come PNG Salva come JPEG
Nome #
Possible role of oxidative stress in the pathogenesis of hypertension. 187
Oxidative stress and diabetes-associated complications. 166
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 149
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 139
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 133
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 131
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 129
The metabolic syndrome--a postprandial disease? 128
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 126
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 125
Acute hyperglycaemia and oxidative stress generation. 122
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 121
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 120
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 119
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 119
Antioxidant therapy in diabetic complications: what is new? 118
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 118
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 117
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 117
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 117
Postprandial glucose regulation: new data and new implications. 116
Meal-generated oxidative stress in type 2 diabetic patients 115
How do we define cure of diabetes? 115
Glucose metabolism and hyperglycemia. 114
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 114
Opiate addict as diabetic patient? 114
Does a common mechanism induce diverse complications of diabetes? 113
Non-enzymatic glycosylation reduces antithrombin III activity 113
Total radical-trapping antioxidant parameter in NIDDM patients. 112
D-lysine and non-enzymatic glycation. 112
Impaired glucose metabolism in heroin and methadone users. 111
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 111
Intra-arterial iloprost for limb ischaemia. 111
Guideline for management of postmeal glucose. 111
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 111
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. 111
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 110
Pregnancy as environmental factor precipitating IDDM. 110
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 110
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 110
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 110
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 110
Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns. 110
Increased glycosylated proteins in opiate addicts. 109
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. 109
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 109
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 108
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 108
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 108
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 108
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 107
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 107
Aspirin and non-enzymatic glycation. 107
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 107
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 106
Mean red blood cell volume, narcotic addiction, and glucose tolerance 106
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 106
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 106
Evidence for a reduced heparin cofactor II biological activity in diabetes. 105
Antioxidant anti-inflammatory treatment in type 2 diabetes. 105
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 105
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. 105
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 105
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. 104
Glycosaminoglycan therapy for long-term diabetic complications? 103
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short- and long-term simvastatin treatment 103
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. 103
Fibrinogen levels in opiate addicts. 103
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 102
Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress. 102
Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. 102
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 102
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP. 101
Point: postprandial glucose levels are a clinically important treatment target. 101
Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. 101
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 101
Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer? 100
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 100
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. 100
Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics. 100
Is oxidative stress the missing link between insulin resistance and atherosclerosis? 99
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 99
Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. 99
Dual effect of beta-endorphin on insulin secretion in man. 98
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 98
Oxidative stress in diabetes. 98
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. 98
International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. 98
Hypothesis: the 'metabolic memory', the new challenge of diabetes. 98
Influence of labile glucose adducts on glycosylated protein assay by aminophenylboronic acid affinity chromatography: in vivo studies. 97
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. 97
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. 97
Tolrestat in the primary prevention of diabetic neuropathy. 97
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. 97
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. 97
Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors. 97
PROactive Study:(r)evolution in the therapy of diabetes? 97
Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation. 96
Fibrinogen plasma levels as a marker of thrombin activation in diabetes. 96
Does postprandial blood glucose matter and why? 96
Totale 10.988
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.262 0 0 0 0 0 0 0 0 0 425 1.067 770
2019/20206.715 421 389 274 1.082 501 1.010 673 775 513 533 133 411
2020/20213.664 63 429 88 534 141 430 289 430 607 125 394 134
2021/20221.932 92 183 69 136 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024302 51 30 9 5 53 47 3 10 83 11 0 0
Totale 22.466